Literature DB >> 9592672

Cochlear implantation after subtotal petrosectomies.

E Bendet1, D Cerenko, T E Linder, U Fisch.   

Abstract

Among cochlear implant candidates there are patients who have abnormal middle and/or inner-ear conditions that make them unsuitable for implantation. Insertion of a foreign body may also be contraindicated in the setting of an existing or potential intracranial communication, or when the ear is prone to infection. Five patients presented with such unfavorable conditions. These included a Mondini dysplasia with persistent cerebrospinal fluid leak, an atretic mastoid with meningocele, chronic otitis media, a transverse petrous bone fracture, and a temporal bone adenoma. All patients underwent subtotal petrosectomies and cochlear implantations. In four cases implantation was performed concomitantly with subtotal petrosectomy, while the remaining case required a two-stage procedure. No complications occurred. The technique is described in detail, and the cases and the indications for surgery are discussed. By obliterating and isolating the tympanomastoid cleft from the outer environment and utilizing the technique of subtotal petrosectomy, a broader spectrum of patients can now be implanted safely.

Entities:  

Mesh:

Year:  1998        PMID: 9592672     DOI: 10.1007/s004050050037

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

Review 1.  Cochlear implantation in patients with acute or chronic middle ear infectious disease: a review of the literature.

Authors:  Catharine A Hellingman; Erwin A Dunnebier
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-14       Impact factor: 2.503

2.  Long-term results of the transattical approach: an alternative technique for cochlear implantation.

Authors:  Miguel Vaca; Auxiliadora Gutiérrez; Rubén Polo; Antonio Alonso; Felipe Álvarez
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-29       Impact factor: 2.503

3.  The role of subtotal petrosectomy in cochlear implant recipients.

Authors:  Xabier Altuna; Leire García; Zuriñe Martínez; Mercedes Fernández de Pinedo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-16       Impact factor: 2.503

4.  Subtotal Petrosectomy and Cochlear Implantation: A Systematic Review and Meta-analysis.

Authors:  Flora Yan; Priyanka D Reddy; Mitchell J Isaac; Shaun A Nguyen; Theodore R McRackan; Ted A Meyer
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-10-15       Impact factor: 6.223

5.  Long-term results of external auditory canal closure and mastoid obliteration in cochlear implantation after radical mastoidectomy: a clinical and radiological study.

Authors:  Vincenzo Vincenti; Enrico Pasanisi; Andrea Bacciu; Salvatore Bacciu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-18       Impact factor: 2.503

6.  Cochlear implantation in chronic otitis media and previous middle ear surgery: 20 years of experience.

Authors:  V Vincenti; E Pasanisi; A Bacciu; S Bacciu; C Zini
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-08       Impact factor: 2.124

7.  Subtotal petrosectomy and mastoid obliteration in adult and pediatric cochlear implant recipients.

Authors:  Christopher F Barañano; Jonathan C Kopelovich; Camille C Dunn; Bruce J Gantz; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2013-12       Impact factor: 2.311

8.  Subtotal Petrosectomy in Cochlear Implant Surgery: Our Experience.

Authors:  Rahul Kurkure; Pabina Rayamajhi; Ashish Castellino; Sandhya Dharmarajan; Ruchima Dham; Kiran Natarajan; Mohan Kameswaran
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-02-12

9.  The use of subtotal petrosectomy in cochlear implant candidates with chronic otitis media.

Authors:  Marcin Szymański; Andre Ataide; Thomas Linder
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-24       Impact factor: 2.503

10.  Subtotal petrosectomy and cochlear implantation.

Authors:  Giulia D'Angelo; Giulia Donati; Andrea Bacciu; Maurizio Guida; Maurizio Falcioni
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-12       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.